Aegerion Pharmaceuticals to Announce First Quarter 2015 Financial Results on Monday, May 4

CAMBRIDGE, Mass., April 21, 2015 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced that the Company will host a conference call and live audio webcast at 5:00 p.m. EDT on Monday, May 4, 2015, to provide a business update and to discuss its first quarter 2015 financial and operating results.

To listen to the live webcast of the call, please visit the "Investors" section of the Company's website at www.aegerion.com. Individuals may also participate in the call via telephone by dialing (866) 516-3002 or (760) 298-5082. Interested parties unable to join the live call may access an archived version of the webcast on Aegerion's website for up to 30 days following the call.

About Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. For more information about the company, please visit www.aegerion.com.

CONTACT: Aegerion Pharmaceuticals, Inc.
         Amanda Murphy, Associate Director, IR & PR
         857-242-5024

Source: Aegerion Pharmaceuticals, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• Capitol Federal Financial (CFFN) Misses Q2 EPS by 1c
• TD Cowen Reiterates Buy Rating on Seagate Technology (STX)